Corona Virus (COVID-19) Now Powerless, As It’s Got A Cure

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Corona Virus (COVID-19) Now Powerless, As It Got A Cure

Just as the wind blew the name of a deadly virus called corona virus (COVID-19) to all ears in the world, so has it with a drug named Actemra, getting some approvals as a cure for COVID-19.

Genentech has secured approval in the US to go ahead with the COVACTA trial to assess the use of its rheumatoid arthritis drug (RA drug) Actemra (tocilizumab) in covid-19 patients.

The company, which is a subsidiary of Roche, will evaluate the safety and efficacy of Actemra given intravenously plus standard of care in hospitalized adults with severe COVID-19 pneumonia. The combination will be pitted against placebo plus standard of care in what will be a phase 3 trial.

Many seem to be so doubtful of the fact that a drug could cure COVID-19 patients, due to the time frame on which it was discovered. Also, many more cannot think less, as the corona virus has posed as a worldwide threat and a more reason for a rapid move to discover its cure.

Roche has announced that the US Food and Drug Administration (FDA) has formally approved its phase 3 trial of Actemra in severely ill COVID-19 patients, who have been hospitalized with pneumonia.


It was first cleared by the FDA as a treatment for rheumatoid arthritis and has also subsequently been approved in juvenile idiopathic arthritis, giant cell arthritis and CRS associated with CAR-T cell therapies for cancer.

SEE ALSO  Which Drugs Work Against Corona Virus?

China’s use of Roche’s Actemra for some COVID-19 patients has put the arthritis drug in the spotlight and set it up for a surge in demand. Roche is trying to stay ahead of that curve by upping production, even as it tests it on COVID-19 for greater effectiveness.

The Swiss drug makers said that it is working urgently to accelerate manufacturing capacity to maximize production of Actemra, when and where it can to boost its global supply.


It pointed out, however, that supply is managed on a country level and within parameters set by governments, so it is working closely with those regulators.

Roche started getting inquires about Actemra from governments around the world after China’s National Health Commission added Actemra to its updated COVID-19 treatment guidelines in early march.

Despite some of the supply and logistics challenges due to COVID-19, Roche has been able to continue to deliver life-saving medicines to patients around the world, thanks to the resilience of its global network.

Get an email when an update on this topic breaks

Share this
Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Source :

Earn up to 80 USD/25,250 NGN Monthly on WahClass

Create a Topic, Discover your niche and make money online, beautifully.

Author

Imaeruaka Joseph .N

Imaeruaka Joseph .N

I believe in sharing wisdom with others. Utilizing life to its maximum and blogging is a call for me . Who is Imaeruaka Joseph? Imaeruaka Joseph also known as Inbuilt-Wisdom JIN, is an indigen of Amesi town, in Aguata local government area, Anambra state. Skills? 1. Copy writer (specialty; sales copy) Currently works with Sky blazer ventures, Niger standard industry ltd, Azodo fish farm. 2. Content creator (short stories, articles, memes and poems) Currently works with Andora Novella, Tis foundation and Medium. 3. Author at Amazon (kindle direct publish) Imaeruaka Joseph up to date has six books published on Amazon. -Marriage forum -Wisdom from its inbuilt -The Compile -Did i have sex? - a memoir -Maintenance of some basic electrical components -The poem stream. Reach out to me via email, [email protected]
Subscribe
Notify of
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Inline Feedbacks
View all comments

Subscribe to Get the Best Articles Weekly

Interests